| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700077 | 重组全人源抗细胞毒T淋巴细胞相关抗原4（CTLA-4）单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2017-08-16 | 苏州信达生物科技有限公司 | Suzhou Xinda Biotechnology Co Ltd | Certificate Issued | 2018-03-06 | view |